These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29360813)

  • 1. Development and validation of a plasma-based melanoma biomarker suitable for clinical use.
    Van Laar R; Lincoln M; Van Laar B
    Br J Cancer; 2018 Mar; 118(6):857-866. PubMed ID: 29360813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma microRNA biomarker of melanoma as a personalised assessment of treatment response.
    van Laar RK; Lincoln MT; van Laar BJ
    Melanoma Res; 2019 Feb; 29(1):19-22. PubMed ID: 30320629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma.
    Saldanha G; Potter L; Shendge P; Osborne J; Nicholson S; Yii N; Varma S; Aslam MI; Elshaw S; Papadogeorgakis E; Pringle JH
    J Invest Dermatol; 2013 May; 133(5):1381-4. PubMed ID: 23303460
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma with BRAF Mutation in Circulating Cell-free DNA despite no Mutation in the Primary Lesion: A Case Report.
    Ashida A; Uhara H; Mikoshiba A; Sakaizawa K; Kumagai N; Koga H; Okuyama R
    Acta Derm Venereol; 2016 Jan; 96(1):128-9. PubMed ID: 26123241
    [No Abstract]   [Full Text] [Related]  

  • 6. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles.
    Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H
    Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor biomarkers in melanoma.
    Ugurel S; Utikal J; Becker JC
    Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis.
    Guo S; Guo W; Li S; Dai W; Zhang N; Zhao T; Wang H; Ma J; Yi X; Ge R; Wang G; Gao T; Li C
    J Invest Dermatol; 2016 May; 136(5):985-993. PubMed ID: 26829037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma.
    Ashida A; Sakaizawa K; Mikoshiba A; Kiniwa Y; Okuyama R
    Acta Derm Venereol; 2019 Nov; 99(12):1184-1185. PubMed ID: 31396634
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant melanoma--markers for progression and prognosis in malignant melanoma.
    Geilen CC; Georgieva J; Milling A; Farthmann B
    Front Radiat Ther Oncol; 2006; 39():120-126. PubMed ID: 16394675
    [No Abstract]   [Full Text] [Related]  

  • 11. The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.
    Kanemaru H; Fukushima S; Yamashita J; Honda N; Oyama R; Kakimoto A; Masuguchi S; Ishihara T; Inoue Y; Jinnin M; Ihn H
    J Dermatol Sci; 2011 Mar; 61(3):187-93. PubMed ID: 21273047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNAs as biomarkers for recurrence in melanoma.
    Friedman EB; Shang S; de Miera EV; Fog JU; Teilum MW; Ma MW; Berman RS; Shapiro RL; Pavlick AC; Hernando E; Baker A; Shao Y; Osman I
    J Transl Med; 2012 Aug; 10():155. PubMed ID: 22857597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma.
    Fogli S; Polini B; Carpi S; Pardini B; Naccarati A; Dubbini N; Lanza M; Breschi MC; Romanini A; Nieri P
    Tumour Biol; 2017 May; 39(5):1010428317701646. PubMed ID: 28466785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.
    Tian R; Liu T; Qiao L; Gao M; Li J
    Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current staging and prognostic factors in melanoma.
    Bartlett EK; Karakousis GC
    Surg Oncol Clin N Am; 2015 Apr; 24(2):215-27. PubMed ID: 25769707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance.
    Nezos A; Lembessis P; Sourla A; Pissimissis N; Gogas H; Koutsilieris M
    Clin Chem Lab Med; 2009; 47(1):1-11. PubMed ID: 19055471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-10b is a prognostic biomarker for melanoma.
    Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH
    Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating biomarkers in malignant melanoma.
    Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
    Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.
    Tan L; Sandhu S; Lee RJ; Li J; Callahan J; Ftouni S; Dhomen N; Middlehurst P; Wallace A; Raleigh J; Hatzimihalis A; Henderson MA; Shackleton M; Haydon A; Mar V; Gyorki DE; Oudit D; Dawson MA; Hicks RJ; Lorigan P; McArthur GA; Marais R; Wong SQ; Dawson SJ
    Ann Oncol; 2019 May; 30(5):804-814. PubMed ID: 30838379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.
    Rapanotti MC; Cugini E; Nuccetelli M; Terrinoni A; Di Raimondo C; Lombardo P; Costanza G; Cosio T; Rossi P; Orlandi A; Campione E; Bernardini S; Blot-Chabaud M; Bianchi L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.